PYC Therapeutics Limited Stock: price and insider trades · Australia

This page follows insider dealings at PYC Therapeutics Limited as filed with ASX, a company from the Health Care sector based in Western Australia, Australia. The group dates from 2001. Over the twelve months to 5 November 2026, 5 filings were filed, from 4 insiders.

The flow runs one way only: 3 insiders bought (4 purchases totalling €318k) and nobody sold on the market. The totals exclude 1 filing filed without an amount. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Dr Rohan Hockings filed the largest purchase, €129k, on 3 November 2026, which represents 0.011% of the company's market value. Those buying include 3 senior executives.

In the case of 1 purchase, another manager of the company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The last purchase on record was published on 5 November 2026, which is 3 days ago. Publication is fast: at least half of the trades appear on ASX on the same day. Until a filing is published, the market cannot know about the trade.

Across the 1,623 companies tracked on its exchange, the median is 5 filings; at 5 filings, this issuer sits right on that mark. The full history, which starts in 2026, counts 4 purchases against no sales.

In the same sector, recent insider purchases at Dynavox Group AB and Vetoquinol SA also feature in our signals. Every figure here comes from the filings published by ASX and describes the past, not future prices; it is not investment advice.